Japan Bets on HIV Drug Trails to Treat Coronavirus as Cases Rises on Ship

Japan intends to start trials of HIV drugs to treat coronavirus sufferers as a rise in the number of cases poses a rising threat to the economy and public well-being, the federal government’s prime spokesperson stated Tuesday.Japan Bets on HIV Drug Trails to Treat Coronavirus as Cases Rises on Ship

The government is preparing so that clinical trials utilizing HIV treatment on the novel coronavirus can start as soon as potential,” Yoshihide Suga informed a briefing; however, he couldn’t say how long it might take to approve a drug’s application.

A further 88 people screened positive for the flu-like virus on the Diamond Princess cruise ship kept off the port of Yokohama, bringing the toll of infected travelers to 542, the Health Ministry stated.

Elsewhere, three more cases had been recorded in Wakayama Prefecture, together with the son of a doctor infected with the coronavirus, local media stated.

As the shrinking economy deepens recession fears, the spread of the virus has urged Tokyo to reduce the size of public gatherings, while some corporations are telling workers to work from home.

HIV medicine had been promoted as a potential cure for the coronavirus, which has killed nearly 1,900 people in China. No therapy has yet confirmed effective against the infection.

People in China have started exploring unorthodox ways to get treated, with some appealing to people with HIV and unauthorized importers for medicine.

In Thailand, doctors stated they seemed to have had some success in treating severe cases of the virus with a mix of medications for flu and HIV.

As demand for surgical masks climbs in Japan, police had been probing the theft of 6,000 masks reported by the Kobe Red Cross Hospital in the central city.

Felicia Broderick

Felicia is the head of the column Medical Devices. An Electronics Engineer from the University of Michigan, Felicia, before opting for technical writing as a profession, worked at firms such as SEH, Leviton, etc. In 2016, she quit her job at Leviton and started taking writing projects as a freelancer. Gradually, she developed an interest in technical writing, and now leading a column here.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *